3-tyr-octreotide has been researched along with Adenoma in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ambrosi, B; Arosio, M; Bazzoni, N; Bonino, C; Faglia, G; Lunghi, F; Sara, R; Spada, A; Spinelli, F | 1 |
Angelberger, P; Luger, A; Neuhold, N; Pantev, T; Sinzinger, H; Virgolini, I | 1 |
Breeman, WA; Hofland, LJ; Lamberts, SW; van Koetsveld, PM; Waaijers, M; Zuyderwijk, J | 1 |
Deng, J; Shi, Y; Shu, C; Yin, J | 1 |
Candrina, R | 1 |
5 other study(ies) available for 3-tyr-octreotide and Adenoma
Article | Year |
---|---|
In vivo detection of somatostatin receptors in patients with functionless pituitary adenomas by means of a radioiodinated analog of somatostatin ([123I]SDZ 204-090).
Topics: Adenoma; Adult; Cell Membrane; Female; Humans; Immunohistochemistry; Injections, Intravenous; Iodine Radioisotopes; Male; Microscopy, Electron; Middle Aged; Octreotide; Pituitary Neoplasms; Radionuclide Imaging; Receptors, Neurotransmitter; Receptors, Somatostatin | 1991 |
Evaluation of somatostatin receptors in human cancer.
Topics: Adenoma; Binding, Competitive; Biomarkers, Tumor; Humans; Neoplasms, Hormone-Dependent; Octreotide; Pituitary Neoplasms; Radioligand Assay; Receptors, Neurotransmitter; Receptors, Somatostatin; Tomography, Emission-Computed, Single-Photon; Tumor Cells, Cultured | 1991 |
Internalization of the radioiodinated somatostatin analog [125I-Tyr3]octreotide by mouse and human pituitary tumor cells: increase by unlabeled octreotide.
Topics: Adenoma; Animals; Cells, Cultured; Dose-Response Relationship, Drug; Growth Hormone; Humans; Hydrogen-Ion Concentration; Iodine Radioisotopes; Mice; Octreotide; Pertussis Toxin; Pituitary Gland; Pituitary Neoplasms; Temperature; Tumor Cells, Cultured; Tyrosine; Virulence Factors, Bordetella | 1995 |
[The role of Ca2+ in the pathogenesis of human pituitary GH-secreting adenomas].
Topics: Adenoma; Biological Transport, Active; Calcimycin; Calcium; Calcium Channel Blockers; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Ionophores; Nicardipine; Nifedipine; Octreotide; Pituitary Neoplasms; Somatostatin; Tumor Cells, Cultured | 1996 |
Paradoxic elevation in serum GH by hypothalamic releasing hormones predicts GH response to acute SMS 201-995 administration.
Topics: Acromegaly; Adenoma; Adult; Female; Gonadotropin-Releasing Hormone; Growth Hormone; Humans; Male; Middle Aged; Octreotide; Pituitary Neoplasms; Prognosis; Thyrotropin-Releasing Hormone | 1991 |